Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Solid Tumor × Interleukin-2 × 1 year × Clear all

Sponsor

Conditions

Melanoma 18 Neoplasm Metastasis 8 Ovarian Neoplasms 7 Lymphoma, Non-Hodgkin 7 Colorectal Neoplasms 7 Leukemia, Myeloid, Acute 6 Carcinoma, Non-Small-Cell Lung 6 Skin Neoplasms 5 Uveal Melanoma 4 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Recurrence 3 Multiple Myeloma 3 Lymphoma, Follicular 3 Lung Neoplasms 3 Leukemia 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Myelodysplastic Syndromes 2 Mesothelioma, Malignant 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, B-Cell, Marginal Zone 2

Interventions

pembrolizumab 6 Injections 5 tislelizumab 4 senaparib 4 Nivolumab 3 Bevacizumab 3 toripalimab 2 spartalizumab 2 Ipilimumab 2 Fluorodeoxyglucose F18 2 zimberelimab 1 tumor-cells apoptosis factor, human 1 tazemetostat 1 sotorasib 1 sintilimab 1 sacituzumab govitecan 1 rucaparib 1 romiplostim 1 osimertinib 1 olaparib 1 magrolimab 1 enzalutamide 1 cemiplimab 1 cedazuridine 1 binimetinib 1 atezolizumab 1 WW Domain-Containing Oxidoreductase 1 Ultrasonography, Doppler 1 Ultrasonography 1 Technetium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡